机译:转移性乳腺癌患者化疗期间CA 15-3血清水平变化的预后意义
Medical Oncology University of Turin Ospedale San Luigi;
Medical Oncology University of Turin Ospedale San Luigi;
Medical Oncology University of Turin Ospedale San Luigi;
Medical Oncology University of Turin Ospedale San Luigi;
Medical Oncology University of Turin Ospedale San Luigi;
Breast Unit Istituti Ospitalieri;
Medical Oncology Istituto Clinica Medica Universitaria University of Sassari;
Medical Oncology Ospedale San Giovanni Battista;
Medical Oncology Istituto Clinica Medica Universitaria University of Sassari;
Medical Oncology Ospedale Civile;
Gynecologic Oncology University of Turin;
Gynecologic Oncology Ospedale Sant’Anna;
Medical Oncology Istituto Tumori di Napoli;
Medical Oncology Ospedale San Giovanni Battista;
Medical Oncology Ospedale San Lazzaro;
Gynecologic Oncology Ospedale Sant’Anna;
Gynecologic Oncology Ospedale Sant’Anna;
Medical Oncology University “Piemonte Orientale”;
Gynecologic Oncology University of Turin;
Medical Oncology University of Turin Ospedale San LuigiUniversità di Torino Ospedale San Luigi di Orbassano;
advanced breast cancer; CA 15-3; clinical response; survival; tumor marker;
机译:转移性乳腺癌患者化疗期间CA 15-3血清水平变化的预后意义。
机译:血清CA 15-3激增的临床意义以及CA 15-3动力学在监测转移性乳腺癌患者化疗反应中的作用。
机译:血清CA 15-3激增的临床意义以及CA 15-3动力学在监测转移性乳腺癌患者化疗反应中的作用
机译:原发性乳腺癌患者术前血清CA15-3,CEA和TPS水平的临床和预后意义
机译:2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床,组织病理学和生物学参数的预后意义
机译:血清HER2细胞外结构域S100ß和CA 15-3水平是转移性乳腺癌患者的独立预后因素
机译:血清HER2细胞外结构域,S100ß和CA 15-3水平是转移性乳腺癌患者的独立预后因素